Memorial Sloan Kettering Cancer Center

@MSKCancerCenter

Where you’re treated first, matters. To make an appointment: 877-871-9362

New York, New York

mskcc.org/news

Joined March 2009

1,930 Following

103.9K Followers

Replies Reposts Media

Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
3h
Coming up at #ESMO26: MSK gastrointestinal medical oncologist @EileenMOReilly will present the AMPLIFY-7P randomized phase 2 study comparing an mKRAS-specific immunotherapy with observation in patients with resected pancreatic ductal adenocarcinoma. 🗓️ Friday, October 23 | 2:32
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
22h
Through a recent collaboration, Memorial Sloan Kettering Cancer Center (MSK) and @OpenEvidence are making precision oncology expertise more accessible within clinicians’ everyday workflows. The collaboration brings OpenEvidence and MSK's OncoKB™ knowledge base together to help
00:00
4
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
23h
When the immune system is weakened by cancer treatment — especially by a stem cell or bone marrow transplant (BMT) for blood cancer — common viruses like herpes simplex virus (HSV) can become a serious problem. For someone who is immunocompromised, an HSV infection can mean
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Oct 20
New research from MSK uncovers an unknown role for immune cells in fueling triple-negative breast cancer; identifies a new strategy for fighting leptomeningeal metastases; finds trastuzumab deruxtecan shows enhanced benefit for patients with ERBB2 mutations in breast cancer; and
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter
Oct 19
🚨: The @FDA has granted accelerated approval to the immunotherapy Jemperli (dostarlimab) for adults with stage 2 or 3 rectal cancer whose tumors have specific genetic characteristics known as mismatch repair-deficient (MMRd) or microsatellite instability-high (MSI-H). The
6